Oct 8, 2026 - 7 AI models call event-driven stocks in the morning session. 4 models beat SPY over the window

Asked Oct 8, 10:20 AM EDT (morning session). Perplexity, GPT-6, Muse Spark 1.1, Gemini 1.5 Pro, Grok 4, Claude Sonnet 5.5 and DeepSeek answered the same standard prompt independently. Window: from Oct 8, 10:20 AM EDT to Oct 9, 10:20 AM EDT, the same time one session later. Benchmark: SPY.

Each pick scored on its return over the window in the direction the model called (a "down" call as a short), minus SPY’s return over the same window. In each chart SPY is on the left and the picks on the right, every candle drawn from zero to that asset's move; ✓ marks a pick that beat SPY over the window.

Model	Correct	Hit rate	Return	SPY	Alpha vs SPY
Perplexity	2/5	40.00%	-0.37%	0.06%	-0.44%
GPT-6	4/5	80.00%	1.00%	0.06%	0.94%
Muse Spark 1.1	1/5	20.00%	-1.59%	0.06%	-1.66%
Gemini 1.5 Pro	4/5	80.00%	1.72%	0.06%	1.66%
Grok 4	2/5	40.00%	-0.03%	0.06%	-0.09%
Claude Sonnet 5.5	3/5	60.00%	0.48%	0.06%	0.42%
DeepSeek	4/5	80.00%	3.18%	0.06%	3.12%

Perplexity

View full picks and reasoning

U.S. equities are pulling back from record highs as Treasury yields climb to multi-year peaks, reviving inflation concerns. The S&P 500 and Nasdaq retreated Wednesday after setting intraday and closing records, with the 10-year yield touching its highest level since 2002. Earnings season is underway with mixed reactions: companies beating estimates but guiding conservatively are being punished, while FDA approvals in biopharma are providing single-stock catalysts. The market is searching for direction as tech rebounds square off against rising yields, higher oil prices, and AI valuation concerns.

1. PEP — confidence 72%. PepsiCo reported Q3 2026 earnings before the open on October 8, beating EPS ($2.34 vs. $2.29) and revenue ($25.27B vs. $24.95B), but cut full-year core EPS growth guidance to 2.5%-3.5% from 5%-7% low end, citing weak North American snack demand and margin pressure. The stock fell 1.58% to $123.73 on October 7 and traded near $124.28 intraday on October 8. The guidance cut overshadows the quarterly beat, and analyst downgrades have piled on. However, the initial selloff may be overdone given the revenue beat and international strength. Emotional continuation risk: shares are near 52-week lows and could see further pressure if investors focus on the North American weakness, but a short-term bounce is possible as the guidance cut was already partially anticipated. Thesis: stock drifts lower into the close as guidance concerns dominate. Risks: defensive rotation or short-covering could limit downside.
   Return: -0.38%; alpha: 0.32%.
2. DAL — confidence 68%. Delta Air Lines is scheduled to report Q3 2026 earnings before the open on Friday, October 9, 2026. Management guided the September quarter to mid-teens revenue growth, 11%-13% operating margin, and EPS of $2.00-$2.50. The stock closed at $82.97 on October 7, down 0.82%, and traded at $82.00 in pre-market on October 8. Analysts are focused on whether premium demand and Amex remuneration can offset rising fuel costs (June quarter fuel was $3.93/gallon, up 75% YoY; September guide assumes ~$3.15). The stock is below its 52-week high of $95.68. Thesis: ahead of earnings, uncertainty around fuel costs and the high bar for Q4 guidance could weigh on the stock, leading to a modest decline. Emotional continuation risk: the stock has been resilient YTD (+20%) but faces a reality check if fuel concerns dominate. Risks: positive premium travel data or raised guidance could spark a rally.
   Return: -1.84%; alpha: 1.77%.
3. STZ — confidence 65%. Constellation Brands reported Q2 FY2027 earnings after the close on October 6, 2026, beating EPS ($3.74 vs. $3.55) and revenue ($2.63B vs. $2.54B), but reiterated FY2027 EPS guidance of $11.20-$11.90, below the ~$11.74 consensus midpoint. The stock initially fell 4%+ after hours, then rebounded 2.35% to $118.39 on October 7, and traded at $116.46 on October 8. Beer depletions were -0.6% (below +0.1% consensus), though management cited September improvement. Thesis: the stock faces emotional continuation risk as investors remain concerned about Modelo momentum and margin pressure. The guidance reiteration (not raise) despite the beat is a negative signal. The stock could drift lower as the market digests the durable demand concerns. Risks: short-covering or positive scanner data could spark a rebound.
   Return: 1.56%; alpha: -1.63%.
4. PFE — confidence 70%. Pfizer announced on October 7-8, 2026 that the FDA approved TUKYSA (tucatinib) in combination with trastuzumab and pertuzumab for maintenance treatment of adults with unresectable, locally advanced, or metastatic HER2+ breast cancer after induction treatment. This expands TUKYSA into the front-line setting. The stock closed at $28.00 on October 7, up 1.82%, on heavy volume (31.2M shares vs. 36M avg). Market cap is ~$159.6B. Thesis: the FDA approval is a positive catalyst that could drive continued momentum, but the stock has underperformed YTD (+12% vs. S&P +14%) and faces overhang from patent expirations (Eliquis, Opdivo 2028). The approval may already be partially priced in given the 1.8% pop on October 7. Emotional continuation risk: the stock could see a modest pullback as traders take profits after the initial pop. Risks: further positive analyst commentary or raised price targets could extend gains.
   Return: 1.36%; alpha: -1.42%.
5. BMY — confidence 60%. Bristol-Myers Squibb received FDA approval on September 30, 2026 to expand CAMZYOS (mavacamten) to adults and pediatric patients (weighing 30 kg or more) with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). The stock closed at $59.70 on October 7, up 0.18%, with avg volume ~11.2M shares. Market cap is ~$122B. Thesis: the label expansion is a positive catalyst, but the stock has already rallied significantly YTD (+15.6% vs. S&P +14%) and faces overhang from Eliquis/Opdivo patent expirations in 2028. The approval was announced on September 30, so some of the positive reaction may have already occurred. Emotional continuation risk: the stock could see modest profit-taking after the recent run-up. Risks: positive analyst commentary on the commercial opportunity or raised price targets could extend gains.
   Return: 1.17%; alpha: -1.24%.

Full prediction and audit record

GPT-6

View full picks and reasoning

Bearish-to-cautious for the October 8–9 prediction window. Rising Treasury yields, elevated oil prices and geopolitical uncertainty are weighing on the broader equity market. Company-specific earnings surprises provide opportunities for relative outperformance, but positive earnings reactions may fade as investors reassess guidance, financing costs and earnings quality. The five selections combine three bearish and two bullish event-driven forecasts. All reference prices are October 8 intraday quotes retrieved from StockAnalysis.com, although quote timestamps vary and are not guaranteed to coincide exactly with prediction_time. The reported 20-day dollar-volume figures are screening proxies calculated using the retrieved stock price multiplied by the published 20-day average share volume, not independently verified averages of daily traded dollar value. All five proxies exceed the $20 million liquidity floor. Event timestamps ending in 00:00:00Z represent the documented event date where an exact occurrence time was unavailable; they must not be interpreted as verified release times. Forecast directions and expected moves refer only to the remaining prediction window, not price changes already observed.

1. APLD — confidence 67%. Bearish forecast despite a substantial positive earnings surprise. Applied Digital reported fiscal first-quarter revenue of $341.9 million, approximately 322% above the year-earlier level, and an adjusted loss of $0.01 per share versus expectations around a $0.29 loss. These are observed results, not anticipated figures. However, the company also reported a substantial net loss, approximately $6.4 billion of debt and significant capital spending requirements. The positive revenue surprise initially attracted buyers, but the October 8 intraday reference quote of $23.57 was below the October 7 closing price of $23.81. The forecast is for additional weakness from the current trading level as investors reconsider financing risk, cash conversion and the sustainability of AI infrastructure spending. High short interest creates significant squeeze risk, and renewed enthusiasm for the revenue beat could produce a sharp countertrend rally. The $23.57 reference is an intraday quote stamped October 8 at 10:14 AM EDT. The dollar-volume figure is a price-times-20-day-average-volume proxy using 18,433,273 shares, not a verified average of daily dollar turnover.
   Return: -0.36%; alpha: 0.30%.
2. LEVI — confidence 65%. Bearish earnings-reaction continuation. Levi Strauss reported adjusted quarterly EPS of $0.48, exceeding the approximately $0.36 consensus, and raised its annual profit outlook. However, tariff refunds contributed materially to the earnings improvement, while revenue of approximately $1.61 billion fell slightly below the expected $1.62 billion. The distinction between recurring operating performance and tariff-related benefits may sustain selling pressure. The stock had already fallen to an October 8 intraday reference of $18.73, down from its October 7 close of $19.51. The forecast anticipates additional selling beyond that already observed decline, rather than counting the opening reaction again. Risks include a relief rally after heavy selling, short-term oversold conditions and renewed investor optimism about holiday demand. The reference quote was stamped October 8 at 9:58 AM EDT. Dollar-volume screening uses 3,189,397 average daily shares multiplied by $18.73; actual average daily dollar turnover was not independently verified.
   Return: -1.64%; alpha: 1.58%.
3. DAL — confidence 62%. Bearish forecast driven by the interaction between an imminent earnings announcement and rapidly rising energy prices. Delta Air Lines is scheduled to report quarterly results on October 9 before the market opens. Consensus forecasts indicate approximately $1.92–$1.94 in quarterly earnings per share, but these are expectations, not reported results. Oil-price volatility and higher fuel-cost expectations may dominate positioning before the release. The October 8 intraday reference price was $82.37, compared with the October 7 close of $82.97. The forecast assumes further downward repricing from the retrieved trading level as investors reduce exposure ahead of earnings. The release may occur before or after the specified window ends at 10:20 UTC on October 9, depending on the actual announcement time; anticipation alone is sufficient to affect prices during October 8. Principal risks are stronger bookings, resilient premium travel demand, favorable management guidance, lower oil prices and a positive earnings surprise. The quote was stamped October 8 at 9:45 AM EDT. Dollar-volume screening uses 7,304,616 average shares per day multiplied by $82.37 rather than a verified daily-dollar-volume series.
   Return: -1.84%; alpha: 1.77%.
4. STZ — confidence 61%. Bullish continuation forecast following stronger-than-expected quarterly earnings and evidence of improving beverage demand. Constellation Brands reported approximately $2.63 billion in quarterly revenue compared with expectations near $2.54 billion, while comparable EPS reached $3.74 versus approximately $3.55 expected. Beer sales increased approximately 5%, and wine and spirits sales increased approximately 17%. These are reported results. The October 8 intraday reference quote was $120.59, following an October 7 close of $118.39, so the existing positive reaction is excluded from the forecast. Additional upside could emerge as investors reassess demand resilience and the company's product portfolio expansion. Important risks include consumer spending weakness, fading post-earnings enthusiasm, profit taking following the recent rally and deterioration in broader market sentiment. The quote was stamped October 8 at 9:58 AM EDT. Dollar-volume screening uses 2,389,869 shares of 20-day average volume multiplied by $120.59; this is a liquidity proxy rather than independently calculated historical dollar turnover.
   Return: 1.56%; alpha: 1.50%.
5. PEP — confidence 59%. Moderately bullish forecast based on a positive market response to earnings despite weaker management guidance. PepsiCo reported approximately $25.27 billion in quarterly revenue and adjusted EPS of $2.34, ahead of consensus expectations near $24.97 billion and $2.30. However, management reduced its annual core EPS growth forecast to approximately 1%–2% from 4%–6%, citing continuing North American margin pressure. The report is an observed event, whereas future operating improvements remain uncertain. The October 8 intraday quote of $126.50 was already above the October 7 closing price of $123.73. The forecast therefore expects only modest additional upside from the retrieved intraday level, potentially supported by defensive rotation and investor expectations of restructuring benefits. Major risks include renewed selling as investors focus on lower guidance, weak beverage volumes, margin pressure and reversal of the initial earnings-driven rally. The reference quote was stamped October 8 at 10:14 AM EDT. Dollar-volume screening uses a published 20-day average of 9,641,738 shares multiplied by the $126.50 quote; this is not an independently verified average of historical daily traded dollar values.
   Return: -0.38%; alpha: -0.45%.

Full prediction and audit record

Muse Spark 1.1

View full picks and reasoning

Earnings season is kicking off with mega-cap staples and airlines in focus. October 8 saw 【entity-PepsiCo¦canonical_name=PepsiCo】 beat small but cut implied outlook, Levi beat big on Oct 7 after close, and TSMC disclosed +51% YoY Q3 sales this morning. Anticipation for Delta Air Lines Oct 9 pre-open is building into lower fuel prices. Volatility likely concentrated in recent reporters with guidance shifts.

1. PEP — confidence 68%. 【entity-PepsiCo¦canonical_name=PepsiCo】 reported Q3 FY2026 Oct 8 before open: EPS $2.34 vs $2.32 consensus and revenue $25.27B vs $25.23B. Beat was small (+0.9%) and coverage notes turnaround still lacks fizz and guidance remains cautious. Stock was $123.73 close Oct 7 and traded up to $126.20 intraday Oct 8 but faces profit taking. Expect fade within window as expectations vs reported facts diverge. Risk is continued buying on activist Elliott $4B stake narrative.
   Return: -0.38%; alpha: 0.32%.
2. TSM — confidence 72%. TSMC disclosed September sales NT$511.86B up 54.6% YoY and Q3 revenue NT$1.49T up 51% YoY on Oct 8 per financial calendar monthly sales bulletin at 13:30 Taipei. Fact is observed, ahead of Oct 15 Q3 earnings call. AI chip demand strong, Samsung record profit warning already priced. Anticipation of Oct 15 beat should lift ADR within window despite high valuation. Risk is profit taking after 60% YTD run.
   Return: -3.31%; alpha: -3.37%.
3. DAL — confidence 65%. Delta Air Lines Q3 2026 earnings officially scheduled before open Friday Oct 9, 2026 with call 10am ET. Consensus $1.92-$1.99 EPS, revenue ~$17.6-18.9B. Event is future within window end, so move is anticipation. Fuel costs falling, demand solid, but Zacks cut to Strong Sell adds uncertainty. Expect positioning for beat to drive up move from now to window end. Risk is guidance on fuel and premium demand disappointment.
   Return: -1.84%; alpha: -1.90%.
4. LEVI — confidence 66%. Levi Strauss reported Q3 2026 Oct 7 after close: EPS $0.48 vs $0.36 est (+31.5% surprise), revenue $1.61B vs $1.65B est slightly light. Raised FY2026 guidance to $1.54-$1.56 from $1.46-$1.52 citing tariff refunds and holiday demand. Price $19.48 on high volume 14.5M vs avg 2.7M. Emotional continuation likely as margin expansion and DTC +11% story builds. Risk is revenue miss and inventory concerns causing reversal.
   Return: -1.64%; alpha: -1.71%.
5. STZ — confidence 60%. Constellation Brands reported Q2 FY2027 (calendar Q3) Oct 6: EPS $3.74 vs $3.55 est beat by $0.19, revenue $2.63B up 6.1% YoY beating. Updated FY2027 guidance $11.20-$11.90 vs $11.74 consensus midpoint slightly soft. Stock $116.36 on 5.5M volume vs 2.2M avg, down from $126 50-day. Post-earnings drift down likely as beer decline -11% YoY underlying noted. Risk is value buying on 2.75% yield.
   Return: 1.56%; alpha: -1.63%.

Full prediction and audit record

Gemini 1.5 Pro

View full picks and reasoning

US stock futures are edging higher as investors digest strong growth signals and rising global trade frictions. The Atlanta Fed GDPNow estimate holding at 3.7% for Q3 points to robust economic momentum, while a widening trade deficit and heating supply chains shift focus to globally exposed sectors. Earnings season is kicking off with mixed results, setting the stage for volatility across individual names.

1. SPOT — confidence 80%. Spotify recently surged over 5% as investors reacted positively to commentary on product launches and monetization. With shares tracking a strong continuation pattern on the back of these product catalysts, we expect upward momentum to carry through the target window. The risk is an abrupt reversal if broader tech market sentiment sours, but the company's clear pricing power and durable margins are currently attracting capital.
   Return: 1.93%; alpha: 1.86%.
2. PEP — confidence 75%. PepsiCo reported its Q3 earnings on October 8, with consensus calling for flat EPS amid inflationary pressures. The business has been struggling with margin pressures, higher input costs, and a sluggish North American volume recovery, compounded by pushback against higher pricing. We anticipate the stock to slide post-earnings as these fundamental drags persist. The main risk to a down call is if the company provided unexpectedly strong forward guidance.
   Return: -0.38%; alpha: 0.32%.
3. CW — confidence 75%. Curtiss-Wright shares dropped 8.00% following a price target reduction from Citi and investor reaction to a CFO transition. Despite solid longer-term aerospace and defense drivers, this executive turnover and analyst downgrade have triggered negative short-term sentiment. We forecast further downside continuation during the session as institutional selling pressure clears. An unexpected defense contract win could introduce upside risk.
   Return: -0.22%; alpha: 0.16%.
4. MRNA — confidence 70%. Moderna climbed almost 5% after Morgan Stanley raised its price target ahead of the upcoming Q3 earnings release. The pre-earnings upgrade signals improving institutional confidence in their commercial execution. We expect this positive momentum to continue attracting capital throughout the target window. Risks include general biotech sector volatility or abrupt profit-taking following the quick gap up.
   Return: 7.90%; alpha: 7.84%.
5. DAL — confidence 65%. Delta Air Lines is officially scheduled to report Q3 results on Friday afternoon, which will highlight travel demand, fuel cost management, and premium revenue trends. Anticipation ahead of the print is expected to drive the stock upward as the market positions for a potentially strong quarter following recent airline pricing stabilization. A downside risk remains if macroeconomic crude oil price shocks deter travel sector buyers.
   Return: -1.84%; alpha: -1.90%.

Full prediction and audit record

Grok 4

View full picks and reasoning

Equity futures lower amid rising oil prices and multi-year high Treasury yields on Middle East escalation risks and inflation concerns. Selective volatility expected around earnings reactions and biotech trial updates within the one-session window, with defensive consumer staples and AI-related names showing relative resilience while rate-sensitive and pure biotech names face pressure.

1. ARGX — confidence 68%. argenx announced simultaneous positive Phase 2 celiac data and discontinuation of Phase 3 UNITY Sjögren’s study for futility on 8 October; the negative late-stage readout dominates and has already driven a double-digit decline. Emotional continuation and position-squaring risk remain elevated into the next session as investors reassess pipeline optionality. Risks include any follow-on commentary that softens the futility interpretation or broader biotech rebound.
   Return: 1.46%; alpha: -1.53%.
2. PENG — confidence 65%. Penguin Solutions reported a substantial Q4 beat (revenue and EPS well above consensus) after the close on 6 October and surged ~13 percent on 7 October. Momentum and AI-infrastructure narrative can extend into the next session before profit-taking typically sets in. Risks are high short-term valuation and any cooling in broader semiconductor sentiment from rising yields.
   Return: -1.70%; alpha: -1.76%.
3. PEP — confidence 62%. PepsiCo reported Q3 results before the open on 8 October that beat EPS and revenue estimates; shares are trading higher intraday. Defensive consumer-staples character and yield environment favor continued relative strength through the window, though any guidance caution on North American volumes remains a risk.
   Return: -0.38%; alpha: -0.45%.
4. DAL — confidence 60%. Delta Air Lines is scheduled to report Q3 earnings before the open on 9 October. Airline stocks frequently exhibit pre-announcement positioning and elevated implied moves; rising oil prices create a headwind that could pressure the stock into the print. Risks include better-than-feared fuel-cost commentary or strong demand metrics that reverse the anticipated direction.
   Return: -1.84%; alpha: 1.77%.
5. STZ — confidence 58%. Constellation Brands reported Q2 fiscal 2027 results after the close on 6 October that beat revenue estimates; shares rose ~2.4 percent on 7 October. Post-earnings momentum in the consumer-staples space can persist for one additional session, especially with beer-volume resilience. Risks include profit-taking after the initial move and broader market pressure from higher yields.
   Return: 1.56%; alpha: 1.50%.

Full prediction and audit record

Claude Sonnet 5.5

View full picks and reasoning

Risk appetite is cautious. The 10-year Treasury yield touched a 24-year high near 5.36% on Oct 7 before easing to about 5.28%, the S&P 500 backed off record highs, and Nvidia, AMD and Intel were weaker in Thursday premarket despite record TSMC sales. Oil and jet fuel remain elevated. I lean toward fading post-event gaps in high-beta AI-infrastructure and squeeze-prone names, and toward owning one scheduled, positively skewed catalyst (Delta earnings before the open on Oct 9). Single-stock calls here are low-conviction and sized in small expected moves. The 20-day dollar volumes are estimated as 20-day average share volume times the latest price, and for DAL, PEP and LEVI the average share volume comes from a Google Finance snapshot dated Sep 25, 2026.

1. DAL — confidence 58%. Delta reports September-quarter results before the open on Fri Oct 9 (company call at 10 a.m. ET), inside the window; this is officially scheduled and has not yet occurred. Sources disagree on the consensus: EPS of roughly $2.0 to $2.2 and revenue of about $17.6B to $19.0B. Delta beat EPS estimates in each of the last several quarters, and the stock fell about 12% over the past month into the print on oil and fuel worries (the 52-week range is $55.03 to $95.68). That leaves expectations modest, while airfares are up more than 23% year over year per CNBC and all 18 to 25 analysts rate it Buy or better. Anticipation alone can lift the stock in the Thursday afternoon session. Risks: a fuel-cost or capacity guidance disappointment, 10-year yields near 5.3% pressuring cyclicals, and a stock beta of about 1.3. Price: 82.58 is a live delayed intraday quote at 10:06 AM EDT on Oct 8 (prior close 82.97). Market cap is 54.01B. The dollar volume of roughly 510M is estimated as 6.18M average shares times the quote.
   Return: -1.84%; alpha: -1.90%.
2. APLD — confidence 48%. Observed: after the close on Oct 7, Applied Digital reported fiscal Q1 2027 revenue of $341.9M versus a consensus of about $124.6M, with adjusted EBITDA of $64.4M, and the stock initially rose about 4% after hours. Since then the gain has reversed and the stock trades at 23.51, down 1.26% at 10:18 AM EDT on Oct 8. Needham cut its target to $70 from $83, saying the beat was almost entirely services revenue, while Wells Fargo raised its target to $55. The company has net debt of about $3.5B, free cash flow of about -$4.5B over the past twelve months, 19% of shares sold short, and a beta of about 6. With 10-year yields at multi-decade highs and AI-infrastructure names under pressure, I expect continued fading of the headline beat over the window. Risks: AI-capex headlines or any new lease announcement can reverse this quickly, and short covering is possible. Price is a live delayed quote; the dollar volume of about 433M is estimated as 18.43M average shares times the quote.
   Return: -0.36%; alpha: 0.30%.
3. WOLF — confidence 46%. Observed: after the close on Oct 7, Wolfspeed announced a conditional 30-year loan commitment of up to $1.5B from the U.S. Department of War (Office of Strategic Capital), and the stock jumped about 20% after hours. Premarket it reached about $35.95, but it has since faded all the way back to 31.67 (10:19 AM EDT, previous close 31.37) on heavy volume, which suggests supply into the pop. The commitment is conditional, the average analyst target is $27.50 (below the price), a registration for 58.15M resale shares is outstanding, the company has negative gross margin and a free cash flow of about -$380M, and the stock has already run far in recent months. The primary risk to this short is a squeeze: short interest is about 49% of shares outstanding (about 83% of float). Expectation: further gradual giveback as the headline premium decays. Price is a live delayed quote; the dollar volume of about 87.7M is estimated as 2.77M 20-day average shares times the quote.
   Return: -2.63%; alpha: 2.56%.
4. PEP — confidence 44%. Observed: PepsiCo reported Q3 on Oct 8 before the open with core EPS of $2.34 versus about $2.30 expected and revenue of $25.27B versus about $24.96B, but cut its full-year core EPS growth outlook to 2.5% to 3.5% (from a prior low end of 5% to 7%) and said North American recovery is taking longer, with additional cost cuts planned. The stock bounced about 2.3% to 126.60 (10:12 AM EDT) from a previous close of 123.73, close to a six-year low, which suggests that a guidance cut was largely priced in (52-week range $123.47 to $171.48). With a low beta of about 0.36, a roughly 4.7% dividend yield and activist involvement (Elliott), I expect modest continued relief as analysts reset targets. Risks: the relief rally fades on Q4 and GLP-1 concerns, rising yields hurt bond-proxy staples, and a stale downside gap remains if the bounce reverses. Price is a live delayed quote; the dollar volume of about 1.04B is estimated as 8.18M average shares times the quote.
   Return: -0.38%; alpha: -0.45%.
5. LEVI — confidence 42%. Observed: Levi Strauss reported Q3 on Oct 7 after the close with adjusted EPS of $0.48 and organic revenue growth of about 5%, and raised its full-year EPS outlook to $1.54 to $1.56, helped by tariff refunds, but it lowered its sales outlook and missed on direct-to-consumer in the US and Europe. Brokers responded with target cuts (BofA to $25, Wells Fargo to $20, JPMorgan to $33, Raymond James to $22), and the stock is down 2.77% at 18.97 at 9:45 AM EDT, close to its 52-week low of 17.72. The earnings quality is low because the beat leans on tariff refunds, and a $100M accelerated buyback offers only partial support. I expect mild continued weakness as target cuts feed through. Risks: oversold bounce, buyback support, and a strong holiday-demand narrative. Price is a live delayed quote about 35 minutes into the session; the dollar volume of about 43.1M is estimated as 2.27M average shares times the quote, and market cap is per StockAnalysis (7.30B).
   Return: -1.64%; alpha: 1.58%.

Full prediction and audit record

DeepSeek

View full picks and reasoning

The tape is risk-off into this window. Hawkish September FOMC minutes released 7 October showed unanimous backing for a 25bp hike to 3.75%-4.00% and left the door open to another hike this year, pushing long-dated Treasury yields toward multi-year highs; oil jumped roughly 4% on fresh Persian Gulf tanker attacks, and US index futures traded lower pre-market on 8 October. Against that backdrop the window's dominant idiosyncratic catalysts are: Delta Air Lines' Q3 2026 earnings before the open on 9 October (options-implied move roughly 6.4%-7.4%); the CMS release of 2027 Medicare Advantage star ratings 'on or around' 8-9 October, which is a binary driver for Medicare-heavy insurers; SpaceX's 9 October lockup tranche (up to 328.4 million Class A shares, about 7% of the locked pool); and continued momentum in Wolfspeed after a conditional $1.5bn/30-year US Department of Defense financing commitment. Because the window is only one session and several 8 October pre-market earnings reactions (PepsiCo, Levi Strauss, Applied Digital, argenx) already occurred before the window opened at 14:20 UTC, I deliberately avoided those and concentrated on catalysts whose outcome lands inside the window or is still being priced.

1. DAL — confidence 62%. Delta reports September-quarter 2026 results before the open on 9 October, with the earnings webcast at 10:00 ET, and options markets price an unusually wide move (about 6.4%-7.4% implied). Consensus sits near $1.88-$1.96 EPS on roughly $17.6-$17.8bn revenue, a ~15% EPS increase year over year, so the bar is high after a ~20% year-to-date rally. Two forces argue for a negative session: the tape is risk-off with hawkish Fed minutes and multi-year-high yields, and crude spiked ~4% on 8 October on Persian Gulf tanker attacks, reviving jet-fuel cost concerns right as Delta prints. Delta also carries a negative post-earnings drift (-4.6% since the last report), a classic 'sell the news' profile for a stock that has already run. The main risk to the call is that Delta has a long record of beats and premium-cabin demand has been strong, so a clean beat-and-raise could squeeze the stock higher. I forecast down, directionally modest relative to the implied move. Reference price is the most recent regular-session close I could verify (7 October, $82.97); I could not obtain a live intraday quote for the mid-session window, so the price basis is a prior close, not a live print. Market cap and liquidity were checked against the floors and pass.
   Return: -1.84%; alpha: 1.77%.
2. HUM — confidence 58%. Humana is the single most levered large-cap name to the CMS 2027 Medicare Advantage star-ratings release expected on or around 8-9 October, a binary event that can reset the stock's bonus-payment economics for the following year. Both Barclays (25 September, upgrade to Overweight) and Cantor Fitzgerald (7 October, upgrade to Overweight with a price target raised to $460 from $300) framed the star-ratings print as the imminent catalyst and argued Humana can flip several contracts, including the large H5216 contract, to bonus status; Humana previously told investors the share of members in 4-star-or-better plans could rise to roughly 45%. The stock, however, fell about 3.2% on 8 October along with the group, so the setup is contentious and the outcome genuinely uncertain, not a pre-announced fact. I forecast up on the analysts' constructive view and the asymmetric payoff if ratings improve, but this is a lower-confidence call than Delta. Key risks: if the ratings disappoint or the release slips past the window, the stock could fall sharply, and the whole Medicare complex is rate-sensitive in the current hawkish tape. Reference price is the most recent verifiable regular-session close (7 October, $396.51); no live intraday quote was available, so the basis is a prior close.
   Return: 13.32%; alpha: 13.25%.
3. SPCX — confidence 60%. SpaceX faces a mechanical supply shock inside the window: up to 328.4 million Class A shares (about 7% of the 180-day locked pool) become eligible for sale on 9 October, the fourth tranche of a rolling unlock schedule. History across recent large-cap IPOs, and SpaceX's own prior tranches, shows that unlock dates add sellable float and pressure the shares, and the stock is still roughly 27% above its IPO price and near multi-month highs, leaving holders with gains to realize. I forecast down. The main risks are that a single unlock date often sees less selling than feared, that demand for AI/datacenter and launch news can absorb supply (Musk-linked AI/NASA headlines have repeatedly lifted the name), and that a large pre-arranged placement could neutralize the flow. Because the float story is well telegraphed, some of the pressure may already be discounted. Reference price is the most recent regular-session close I could verify (7 October, $167.60); no live intraday quote was available. Market cap and dollar volume are far above the floors.
   Return: -2.15%; alpha: 2.08%.
4. UNH — confidence 52%. UnitedHealth is a second, more liquid way to trade the same CMS 2027 star-ratings catalyst as Humana, and it also carries anticipation into its own 13 October earnings (confirmed for before the open on 13 October, outside this window but close enough to influence positioning). Cantor has publicly argued that market worries about UnitedHealth's CAHPS-driven star performance are misplaced, and the group sold off on 8 October (-1.5% for UNH), leaving room for a relief move if ratings hold up. UNH has less star-rating upside than Humana because 78% of its members were already in 4-star-or-better plans in the prior cycle, so my expected move is smaller and confidence is lower. Key risks: a downgrade in UNH's star contracts would hit the stock hard, the hawkish rate backdrop pressures the whole managed-care complex, and the ratings release could slip past the window, in which case the stock trades on 13 October earnings anticipation alone. Reference price is the most recent verifiable regular-session close (7 October, $375.98); no live intraday quote was available.
   Return: 1.24%; alpha: 1.17%.
5. WOLF — confidence 45%. Wolfspeed disclosed a conditional $1.5bn, 30-year financing commitment from the US Department of Defense, a company-specific, non-earnings catalyst that sent the shares up more than 15% pre-market on 8 October after a 28% after-hours move, and that continues to be digested during the window. The stock is a high-beta, heavily shorted post-restructuring name, and a confirmed federal backstop of this size is the kind of news that can produce multi-day momentum as analysts re-rate the balance sheet and the AI/power-semiconductor demand story. I forecast up, but with the lowest confidence in the book: the first leg of the move already occurred pre-market, so the window's return depends on whether buyers keep pressing or 'sell the news' takes over, and the intraday range on 8 October was extremely wide ($30.16-$40.50), which cuts both ways. Risks include reversal after a vertical move, dilution/financing terms embedded in a 'conditional' commitment, and the broader semiconductor sell-off in this tape. Reference price is the most recent verifiable regular-session close (7 October, $31.37); no live intraday quote was available. Market cap ~$1.66bn and dollar volume clear the floors, but the name is small and volatile.
   Return: -2.63%; alpha: -2.69%.

Full prediction and audit record

How models have done in Event Gaps

ForecastNest's own settled Event Gaps runs at this horizon, up to and including this one. Members' own research is not counted. Event Gaps forecasts must have been created during regular US market hours to enter these statistics. Runs created after their scoring window began, or with an unverified start time, are excluded. The chart is the average alpha vs SPY per run. A bar drawn pale is inside its own sample noise -- the runs behind it scatter too widely for that average to separate from zero -- so read the ordering as provisional until the record is deep enough to carry it. The table below adds how many of the five picks beat SPY, which is a steadier measure on a short record because it counts several picks a run rather than one result.

Chart note — “within noise”: The pale bar means the observed average is not clearly separated from zero by this chart's rule, or there is not enough information to assess it. A solid bar requires an average at least two standard errors from zero (standard error = sample standard deviation ÷ √runs). Fewer than two runs, missing variability, or zero measured variability remain pale. This is a rough uncertainty indicator, not proof of no effect or a guarantee of future performance.

Model	Runs	Avg picks with positive alpha	Avg alpha vs SPY
Claude Opus 5.5	3	53.33%	+0.85%
DeepSeek	11	58.64%	+0.76%
Grok 4.5	9	46.67%	+0.69%
ChatGPT	1	60.00%	+0.50%
Gemini 1.5 Pro	10	52.00%	+0.29%
Perplexity	9	40.00%	+0.00%
Grok 4	1	40.00%	-0.09%
GPT-6	3	46.67%	-0.15%
Claude Opus 5	1	40.00%	-0.25%
Gemini 3 Pro	1	40.00%	-0.27%
Muse Spark 1.1	11	45.45%	-0.49%
Claude Sonnet 5.5	7	37.14%	-1.16%
GPT-5.6 Sol	7	40.00%	-1.42%
Kimi	1	20.00%	-5.18%

View settlement prices

Symbol	Start	End	Source	Notes
APLD	23.58000000	23.49500000	https://finance.yahoo.com/quote/APLD/history/
ARGX	800.57000000	812.28010000	https://finance.yahoo.com/quote/ARGX/history/
BMY	58.84500000	59.53500000	https://finance.yahoo.com/quote/BMY/history/
CW	509.38000000	508.26000000	https://finance.yahoo.com/quote/CW/history/
DAL	82.81000000	81.29000000	https://finance.yahoo.com/quote/DAL/history/
HUM	381.08000000	431.83000000	https://finance.yahoo.com/quote/HUM/history/
LEVI	18.85500000	18.54500000	https://finance.yahoo.com/quote/LEVI/history/
MRNA	195.61000000	211.05990000	https://finance.yahoo.com/quote/MRNA/history/
PENG	72.86500000	71.62500000	https://finance.yahoo.com/quote/PENG/history/
PEP	126.30000000	125.81500000	https://finance.yahoo.com/quote/PEP/history/
PFE	27.61000000	27.98500000	https://finance.yahoo.com/quote/PFE/history/
SPCX	165.47000000	161.92000000	https://finance.yahoo.com/quote/SPCX/history/
SPOT	520.46000000	530.49000000	https://finance.yahoo.com/quote/SPOT/history/
SPY	775.91000000	776.40000000	https://finance.yahoo.com/quote/SPY/history/
STZ	120.59510000	122.48000000	https://finance.yahoo.com/quote/STZ/history/
TSM	468.48650000	452.98500000	https://finance.yahoo.com/quote/TSM/history/
UNH	370.54000000	375.12000000	https://finance.yahoo.com/quote/UNH/history/
WOLF	31.67000000	30.83840000	https://finance.yahoo.com/quote/WOLF/history/

Standard prompt event-gap-v12, SHA-256 979328e39e9a94284aff862797225724c2288359f79aff0f590f1e8e6743e60c. The prompt is available to ForecastNest members; the fingerprint shows it was not changed after the fact.

Calculation: event-gap-v3-window-direction.